KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zimmer Biomet Holdings (ZBH) Equity Ratio (2016 - 2025)

Zimmer Biomet Holdings has reported Equity Ratio over the past 17 years, most recently at 0.55 for Q4 2025.

  • Quarterly results put Equity Ratio at 0.55 for Q4 2025, down 5.77% from a year ago — trailing twelve months through Dec 2025 was 0.55 (down 5.77% YoY), and the annual figure for FY2025 was 0.55, down 5.77%.
  • Equity Ratio for Q4 2025 was 0.55 at Zimmer Biomet Holdings, up from 0.54 in the prior quarter.
  • Over the last five years, Equity Ratio for ZBH hit a ceiling of 0.59 in Q2 2024 and a floor of 0.52 in Q1 2021.
  • Median Equity Ratio over the past 5 years was 0.57 (2022), compared with a mean of 0.56.
  • Biggest five-year swings in Equity Ratio: increased 11.25% in 2021 and later decreased 7.47% in 2025.
  • Zimmer Biomet Holdings' Equity Ratio stood at 0.54 in 2021, then rose by 5.73% to 0.57 in 2022, then grew by 1.75% to 0.58 in 2023, then grew by 0.52% to 0.58 in 2024, then dropped by 5.77% to 0.55 in 2025.
  • The last three reported values for Equity Ratio were 0.55 (Q4 2025), 0.54 (Q3 2025), and 0.55 (Q2 2025) per Business Quant data.